Advisory Editor profile: John Robinson

Profile: Professor John Mendelsohn.

E-mail address: jan 1574-7891/$ – see fron doi:10.1016/j.molonc.2 Lessons learnt from Hurricane Ike last autumn are now guiding John Mendelsohn in his management of the largest US cancer institute in the current financial down turn. ‘‘We face critical financial pressures due to decreasing federal research support, cutbacks in Medicaid and Medicare, reduced philanthropic gifts, and increases in ...

John von Neumann COLLECTED WORKS GENERAL EDITOR

THE ISOLATION OF AN UNREDUCED SOLUBLE OVOMUCIN By DAVID S. ROBINSON* and JOHN B. MONSEY

1. New preparations of reduced carboxymethylated /3-ovomucin (S-carboxymethylf,-ovomucin) were homogeneous by sedimentation analysis, analytical sedimentation to equilibrium in CsCI gradients, and disc electrophoresis in sodium dodecyl sulphate. 2. Degradation of S-carboxymethyl-f/-ovomucin with either CNBr or trypsin indicated the presence of a subunit (approx. mol.wt. 112300). 3. Electron mic...

Editor profile: Luqi Huang and Wei Gao

Academy of Engineering, the executive vice president of China Academy of Chinese Medical Sciences, the director of National Resource Center for Chinese Materia Medica, a leading researcher, a group leader of the experts guiding group for the national survey on Chinese Medicinal Material Resources, the head of Chinese Medicinal Material Resources innovation team of key area issued by Ministry of...

Editor Profile: Guest Editor of Special Issue on Targets and Anticancer Drug Research

China and became a professor since 2002. Dr. Fu has long standing research interests in cancer pharmacology and chemotherapy, especially the cancer multidrug resistance and TKIs' resistance as well as personalized chemotherapy. His original contribution includes establishing tumor living tissue susceptibility system in vitro, discovering drugs targeting ABC transporters to reversing MDR, and de...